Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS ▾
BFRI	Biofrontera Inc. Manufacturing · Year ended 2025-12-31 · USD	$41.70M	-$10.54M	-25.3%	-100.5%	11.7%	-$1.04
RFL	Rafael Holdings, Inc. Manufacturing · Year ended 2025-07-31 · USD	$917.0K	-$30.52M	n/m	-31.0%	44.0%	-$1.04
ACTU	Actuate Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$22.23M	n/a	-280.5%	n/a	-$1.06
LNAI	Lunai Bioworks Inc. Manufacturing · Year ended 2025-06-30 · USD	n/a	-$178.01M	n/a	n/a	n/a	-$1.08
ZYME	Zymeworks Inc. Manufacturing · Year ended 2025-12-31 · USD	$105.97M	-$81.13M	-76.6%	-30.2%	38.9%	-$1.08
ATNM	Actinium Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$90.0K	-$33.89M	n/m	-432.6%	n/a	-$1.09
SEPN	Septerna, Inc. Manufacturing · Year ended 2025-12-31 · USD	$45.95M	-$48.88M	-106.4%	-12.8%	n/m	-$1.10
KRSA	Korsana Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.07M	-$3.53M	-170.1%	-38.8%	3.7%	-$1.11
ADCT	ADC Therapeutics SA Manufacturing · Year ended 2025-12-31 · USD	$81.36M	-$142.62M	-175.3%	n/a	14.9%	-$1.12
ARVN	Arvinas, Inc. Manufacturing · Year ended 2025-12-31 · USD	$262.60M	-$80.80M	-30.8%	-18.6%	-0.3%	-$1.14
ANTX	AN2 Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$35.17M	n/a	-66.3%	n/a	-$1.16
BMEA	Biomea Fusion, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$61.80M	n/a	-209.1%	n/a	-$1.18
FHTX	Foghorn Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$30.91M	-$74.28M	-240.3%	n/a	36.8%	-$1.18
FULC	Fulcrum Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$74.88M	n/a	-21.5%	-100.0%	-$1.18
MGNX	Macrogenics Inc Manufacturing · Year ended 2025-12-31 · USD	$149.50M	-$74.62M	-49.9%	-134.2%	-0.3%	-$1.18
DARE	Dare Bioscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.03M	-$13.40M	n/m	-471.4%	n/m	-$1.20
WVE	Wave Life Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$42.73M	-$204.38M	-478.3%	-39.4%	-60.5%	-$1.21
DSGN	Design Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$69.79M	n/a	-32.8%	n/a	-$1.22
XNCR	Xencor Inc Manufacturing · Year ended 2025-12-31 · USD	$125.58M	-$91.92M	-73.2%	-14.5%	13.7%	-$1.24
NMAD	Nomad Power Solutions, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$6.08M	n/a	-62.9%	n/a	-$1.26
COYA	Coya Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.95M	-$21.23M	-267.1%	-49.3%	123.6%	-$1.27
IMRX	Immuneering Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$56.02M	n/a	-25.6%	n/a	-$1.27
LFCR	Lifecore Biomedical, Inc. Manufacturing · Year ended 2025-05-25 · USD	$128.87M	-$38.72M	-30.0%	n/m	0.5%	-$1.27
IDYA	IDEAYA Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$218.71M	-$113.70M	-52.0%	-11.1%	n/m	-$1.28
PYXS	Pyxis Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.86M	-$79.62M	-574.5%	-149.1%	-14.2%	-$1.28

Rows per page: 2550 100